Inmar Intelligence

Inmar operates a B2B technology and services model spanning martech/retail media and healthcare compliance and supply-chain workflows. On the marketing side, it provides platforms that allow retailers and advertisers to manage loyalty programmes, promotions and retail media campaigns, using data to plan, execute and measure advertising tied to sales outcomes. On the healthcare side, it delivers subscription platforms for pharmaceutical traceability, medication workflow management and product recall coordination, helping organisations maintain regulatory compliance and operational efficiency.

Value is created by consolidating fragmented workflows (promotions, media, settlement, recalls, DSCSA compliance, medication tracking) into integrated platforms that reduce administrative overhead, support regulatory obligations and enable additional revenue streams (for retailers) or risk reduction (for healthcare providers). Long-term contracts, integrations with customer systems and GPO or network agreements lock in recurring usage and data flows, reinforcing switching costs and recurring revenue visibility.

Inmar, Inc. is a United States–based technology and services company focused on retail media, marketing technology and healthcare supply-chain, compliance and recall management. It operates self-service loyalty and retail media platforms for retailers and brands, while also providing cloud-based compliance, traceability and workflow tools for hospitals, pharmacies and healthcare supply chains.

The company generates revenue from enterprise software subscriptions, media and promotion fees, and associated professional services. Core customers are retailers and consumer packaged goods advertisers using its martech and retail media platforms, and hospitals, health systems, pharmacies, group purchasing organisations and manufacturers using its healthcare compliance, recall and supply-chain solutions. Inmar has divested its post-purchase and retail returns operations and is currently owned by private equity investor ABRY Partners.